Pharmaceutical Fine Chemicals Market Analysis by Application (Cardiovascular, Neurological, Oncological, Diabetes, Respiratory, Gastrointestinal, Musculoskeletal), by Type, by Size and Segment Forecasts, 2014 - 2025

  • ID: 4396424
  • Report
  • 122 pages
  • Grand View Research
1 of 4

FEATURED COMPANIES

  • Albemarle Corporation
  • Chemada Fine Chemicals
  • Denisco Chemicals
  • GlaxoSmithKline plc
  • Kenko Corporation
  • Pfizer Inc
  • MORE

The global pharmaceutical fine chemicals market size was valued at USD 78.20 billion in 2016. Rising aging population along with rising health consciousness among consumers is expected to propel demand growth over the forecast period.
Pharmaceutical fine chemicals are also known as fine chemicals. These are pure substances as compared to generic commodity chemicals. These are characterized by their low volume and higher price structure. These pure chemicals are mixed with basic chemicals to convert into complex chemicals, which have varied applications in various fields such as agriculture, pharmaceuticals, and nutraceuticals.

The U.S. market was valued at USD 22.46 billion in 2016. The raw material utilized for the manufacturing of pharmaceutical fine chemicals are governed by FDA U.S. The organization has set various quality standards for the raw materials and products manufactured from pharmaceutical fine chemicals. EPA U.S. has laid down guidelines, which encourage setting up of environment-friendly industrial facilities for pharmaceutical fine chemicals, which are also cost effective.
The global market is characterized by major industry participants focusing on the R&D activities. In order, to capture the emerging opportunities in regions such as Asia Pacific and Central & South America, companies are setting up manufacturing facilities to increase their regional footprint.

Regional Insights
North America emerged as the largest consumer in 2016, and the market was valued at USD 29.0 billion in 2016. North America region is characterized by the presence of strict laws and regulations about manufacturing as well as consumption. The claims made by the drug producers regarding the efficacy of their product need to be validated by the proper regulatory agencies before the product launch. The region is also characterized by people having a strong inclination towards preventive healthcare. Also, wide awareness about drug use is also a key regional characteristic.

Asia Pacific is expected to witness the highest growth rate over the next eight years. High population growth in countries such as China and India coupled with the rising disposable income as well the increasing standard of living is catering to market growth in the region. Rising government healthcare expenditure in the region is also expected to benefit the market demand over the forecast period.

Competitive Insights
Pharmaceutical fine chemical manufacturers have been adopting various strategies such as new product development, joint ventures, and collaborations. These strategies have been adopted to increase market penetration and cater to changing technological requirements for different end-use applications in their specific regions.

Companies operating in the Asia Pacific region suffered a severe setback due to the strict regulatory checks imposed by the western regulatory agencies. The formidable advantage that the enterprises in the region possess about the lower labor costs and environmental costs are rapidly being offset as both these costs are escalating in the region. The region is characterized by the presence of a large number of small players having in line manufacturing capabilities as compared to their western counterparts.

Wide distribution channels along with growing competition among players are expected to open new avenues over the next eight years. Industry participants include Angelini Acraf S.p.A., W.R. Grace & Co., Kenko Corporation, and Albemarle Corporation.

Segments covered in the report
This report forecasts revenue growth at global, regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, The report has segmented the global pharmaceutical fine chemical market on the basis of application, type, size, product and region:

Application Outlook (Revenue, USD Billion, 2014 - 2025)

  • Cardiovascular
  • Neurology
  • Oncology
  • Infectious diseases
  • Metabolic system
  • Diabetes
  • Respiratory disease
  • Gastrointestinal diseases
  • Musculoskeletal diseases
  • Others

Type Outlook (Revenue, USD Billion, 2014 - 2025)

  • Proprietary
  • Non-proprietary

Size Outlook (Revenue, USD Billion, 2014 - 2025)

  • Small molecules
  • Big molecules

Product Outlook (Revenue, USD Billion, 2014 - 2025)

  • Basic building blocks
  • Advanced intermediates
  • Active ingredients

Regional Outlook (Revenue, USD Billion, 2014 - 2025)
North America

  •     U.S.

Europe

  •     Germany
  •     UK

Asia Pacific

  •     China
  •     India
  •     Japan

Central & South America
Middle East & Africa



PLEASE NOTE:
This report will be completed after order and will take approximately 1-2 business days after the confirmation of payment.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Albemarle Corporation
  • Chemada Fine Chemicals
  • Denisco Chemicals
  • GlaxoSmithKline plc
  • Kenko Corporation
  • Pfizer Inc
  • MORE

Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research scope and assumptions
1.3 List of data sources

Chapter 2 Executive Summary
2.1 Pharmaceutical fine chemicals - Industry snapshot and key buying criteria

Chapter 3 Pharmaceutical Fine Chemicals Market Variables, Trends and Scope
3.1 Market segmentation and scope
3.2 Penetration & growth prospect mapping
3.3 Value chain analysis
3.4 Market dynamics
3.5 Market driver analysis
3.5.1 Pharmaceutical fine chemicals – Key market driver impact
3.5.1.1 Increasing demand for preventive healthcare
3.5.1.2 Aging population
3.5.2 Pharmaceutical fine chemicals – Key market restraints impact
3.5.2.1 Overcapacity of manufacturing plants
3.6 Key opportunities prioritized
3.7 Industry analysis - Porter’s
3.8 PESTLE analysis

Chapter 4 Pharmaceutical Fine Chemicals: Application Estimates & Trend Analysis
4.1 Global pharmaceutical fine chemicals market share by application, 2016 & 2025
4.2 Cardiovascular
4.2.1 Market estimates & forecasts, in cardiovascular, 2014 - 2025 (USD Billion)
4.2.2 Market estimates & forecasts, in cardiovascular, by region, 2014 - 2025 (USD Billion)
4.3 Neurology
4.3.1 Market estimates & forecasts, in neurology, 2014 - 2025 (USD Billion)
4.3.2 Market estimates & forecasts, in neurology, by region, 2014 - 2025 (USD Billion)
4.4 Oncology
4.4.1 Market estimates & forecasts, in oncology, 2014 - 2025 (USD Billion)
4.4.2 Market estimates & forecasts, in oncology, by region, 2014 - 2025 (USD Billion)
4.5 Infectious diseases
4.5.1 Market estimates & forecasts, in infectious diseases, 2014 - 2025 (USD Billion)
4.5.2 Market estimates & forecasts, in infectious diseases, by region, 2014 - 2025 (USD Billion)
4.6 Metabolic system
4.6.1 Market estimates & forecasts, in metabolic system, 2014 - 2025 (USD Billion)
4.6.2 Market estimates & forecasts, in metabolic system, by region, 2014 - 2025 (USD Billion)
4.7 Diabetes
4.7.1 Market estimates & forecasts, in diabetes, 2014 - 2025 (USD Billion)
4.7.2 Market estimates & forecasts, in diabetes, by region, 2014 - 2025 (USD Billion)
4.8 Respiratory diseases
4.8.1 Market estimates & forecasts, in respiratory diseases, 2014 - 2025 (USD Billion)
4.8.2 Market estimates & forecasts, in respiratory diseases, by region, 2014 - 2025 (USD Billion)
4.9 Gastrointestinal diseases
4.9.1 Market estimates & forecasts, in gastrointestinal diseases, 2014 - 2025 (USD Billion)
4.9.2 Market estimates & forecasts, in gastrointestinal diseases, by region, 2014 - 2025 (USD Billion)
4.10 Musculoskeletal diseases
4.10.1 Market estimates & forecasts, in musculoskeletal diseases, 2014 - 2025 (USD Billion)
4.10.2 Market estimates & forecasts, in musculoskeletal diseases, by region, 2014 - 2025 (USD Billion)
4.11 Other applications
4.11.1 Market estimates & forecasts, in other application, 2014 - 2025 (USD Billion)
4.11.2 Market estimates & forecasts, in other application, by region, 2014 - 2025 (USD Billion)

Chapter 5 Pharmaceutical Fine Chemicals: Type Estimates & Trend Analysis
5.1 Global pharmaceutical fine chemicals market share by type, 2016 & 2025
5.2 Proprietary
5.2.1 Market estimates & forecasts, 2014 - 2025 (USD Billion)
5.2.2 Market estimates & forecasts, by region, 2014 - 2025 (USD Billion)
5.3 Non-proprietary
5.3.1 Market estimates & forecasts 2014 - 2025 (USD Billion)
5.3.2 Market estimates & forecasts, by region, 2014 - 2025 (USD Billion)

Chapter 6 Pharmaceutical Fine Chemicals: Chemicals Size Estimates & Trend Analysis
6.1 Global pharmaceutical fine chemicals market share by chemicals, 2016 & 2025
6.2 Small molecules
6.2.1 Market estimates & forecasts, in small molecules, 2014 - 2025 (USD Billion)
6.2.2 Market estimates & forecasts, in small molecules, by region, 2014 - 2025 (USD Billion)
6.3 Big molecules
6.3.1 Market estimates & forecasts, in big molecules, 2014 - 2025 (USD Billion)
6.3.2 Market estimates & forecasts, in big molecules, by region, 2014 - 2025 (USD Billion)

Chapter 7 Pharmaceutical Fine Chemicals: Product Estimates & Trend Analysis
7.1 Global pharmaceutical fine chemicals market share by product, 2016 & 2025
7.2 Basic building blocks
7.2.1 Market estimates & forecasts, in basic building blocks, 2014 - 2025 (USD Billion)
7.2.2 Market estimates & forecasts, in basic building blocks, by region, 2014 - 2025 (USD Billion)
7.3 Advanced intermediates
7.3.1 Market estimates & forecasts, in advanced intermediates, 2014 - 2025 (USD Billion)
7.3.2 Market estimates & forecasts, in advanced intermediates, by region, 2014 - 2025 (USD Billion)
7.4 Active ingredients
7.4.1 Market estimates & forecasts, in active ingredients, 2014 - 2025 (USD Billion)
7.4.2 Market estimates & forecasts, in active ingredients, by region, 2014 - 2025 (USD Billion)

Chapter 8 Pharmaceutical Fine Chemicals Market : Regional Estimates & Trend Analysis
8.1 Global pharmaceutical fine chemicals market share by region, 2016 & 2025
8.2 North America
8.2.1 Market estimates & forecasts, 2014 - 2025 (USD Billion)
8.2.2 Market estimates & forecasts by application, 2014 - 2025 (USD Billion)
8.2.3 Market estimates & forecasts by type, 2014 - 2025 (USD Billion)
8.2.4 Market estimates & forecasts by size, 2014 - 2025 (USD Billion)
8.2.5 Market estimates & forecasts by product, 2014 - 2025 (USD Billion)
8.2.6 U.S.
8.2.6.1 Market estimates & forecasts, 2014 - 2025 (USD Billion)
8.2.6.2 Market estimates & forecasts by application, 2014 - 2025 (USD Billion)
8.2.6.3 Market estimates & forecasts by type, 2014 - 2025 (USD Billion)
8.2.6.4 Market estimates & forecasts by size, 2014 - 2025 (USD Billion)
8.2.6.5 Market estimates & forecasts by product, 2014 - 2025 (USD Billion)
8.3 Europe
8.3.1 Market estimates & forecasts, 2014 - 2025 (USD Billion)
8.3.2 Market estimates & forecasts by application, 2014 - 2025 (USD Billion)
8.3.3 Market estimates & forecasts by type, 2014 - 2025 (USD Billion)
8.3.4 Market estimates & forecasts by size, 2014 - 2025 (USD Billion)
8.3.5 Market estimates & forecasts by product, 2014 - 2025 (USD Billion)
8.3.6 Germany
8.3.6.1 Market estimates & forecasts, 2014 - 2025 (USD Billion)
8.3.6.2 Market estimates & forecasts by application, 2014 - 2025 (USD Billion)
8.3.6.3 Market estimates & forecasts by type, 2014 - 2025 (USD Billion)
8.3.6.4 Market estimates & forecasts by size, 2014 - 2025 (USD Billion)
8.3.6.5 Market estimates & forecasts by product, 2014 - 2025 (USD Billion)
8.3.7 UK
8.3.7.1 Market estimates & forecasts, 2014 - 2025 (USD Billion)
8.3.7.2 Market estimates & forecasts by application, 2014 - 2025 (USD Billion)
8.3.7.3 Market estimates & forecasts by type, 2014 - 2025 (USD Billion)
8.3.7.4 Market estimates & forecasts by size, 2014 - 2025 (USD Billion)
8.3.7.5 UMarket estimates & forecasts by product, 2014 - 2025 (USD Billion)
8.4 Asia Pacific
8.4.1 Market estimates & forecasts, 2014 - 2025 (USD Billion)
8.4.2 Market estimates & forecasts by application, 2014 - 2025 (USD Billion)
8.4.3 Market estimates & forecasts by type, 2014 - 2025 (USD Billion)
8.4.4 Market estimates & forecasts by size, 2014 - 2025 (USD Billion)
8.4.5 Market estimates & forecasts by product, 2014 - 2025 (USD Billion)
8.4.6 China
8.4.6.1 Market estimates & forecasts, 2014 - 2025 (USD Billion)
8.4.6.2 Market estimates & forecasts by application, 2014 - 2025 (USD Billion)
8.4.6.3 Market estimates & forecasts by type, 2014 - 2025 (USD Billion)
8.4.6.4 Market estimates & forecasts by size, 2014 - 2025 (USD Billion)
8.4.6.5 CMarket estimates & forecasts by product, 2014 - 2025 (USD Billion)
8.4.7 India
8.4.7.1 Market estimates & forecasts, 2014 - 2025 (USD Billion)
8.4.7.2 Market estimates & forecasts by application, 2014 - 2025 (USD Billion)
8.4.7.3 Market estimates & forecasts by type, 2014 - 2025 (USD Billion)
8.4.7.4 Market estimates & forecasts by size, 2014 - 2025 (USD Billion)
8.4.7.5 Market estimates & forecasts by product, 2014 - 2025 (USD Billion)
8.4.8 Japan
8.4.8.1 Market estimates & forecasts, 2014 - 2025 (USD Billion)
8.4.8.2 Market estimates & forecasts by application, 2014 - 2025 (USD Billion)
8.4.8.3 Market estimates & forecasts by type, 2014 - 2025 (USD Billion)
8.4.8.4 Market estimates & forecasts by size, 2014 - 2025 (USD Billion)
8.4.8.5 Market estimates & forecasts by product, 2014 - 2025 (USD Billion)
8.5 Central South America (CSA)
8.5.1 Market estimates & forecasts by application, 2014 - 2025 (USD Billion)
8.5.2 Market estimates & forecasts by type, 2014 - 2025 (USD Billion)
8.5.3 Market estimates & forecasts by size, 2014 - 2025 (USD Billion)
8.5.4 Market estimates & forecasts by product, 2014 - 2025 (USD Billion)
8.6 Middle East & Africa (MEA)
8.6.2 Market estimates & forecasts by application, 2014 - 2025 (USD Billion)
8.6.3 Market estimates & forecasts by type, 2014 - 2025 (USD Billion)
8.6.4 Market estimates & forecasts by size, 2014 - 2025 (USD Billion)
8.6.5 Market estimates & forecasts by product, 2014 - 2025 (USD Billion)

Chapter 9 Competitive Landscape
9.1 Vendor Landscape
9.2 Competitive Environment
9.3 Strategy Framework

Chapter 10 Company Profiles
10.1 Denisco Chemicals
10.1.1 Company overview
10.1.2 Product benchmarking
10.2 Albemarle Corporation
10.2.1 Company overview
10.2.2 Financial performance
10.2.3 Product benchmarking
10.3 Kenko Corporation
10.3.1 Company overview
10.3.2 Product benchmarking
10.4 W. R. Grace & Co.
10.4.1 Company overview
10.4.2 Product benchmarking
10.5 Chemada Fine Chemicals
10.5.1 Company Overview
10.5.2 Product Benchmarking
10.6 Syntor Fine Chemicals
10.6.1 Company overview
10.6.2 Product benchmarking
10.7 Johnson Matthey Fine Chemicals
10.7.1 Company overview
10.7.2 Financial performance
10.7.3 Product benchmarking
10.7.4 Strategic Initiatives
10.8 Pfizer Inc
10.8.1 Company overview
10.8.2 Financial performance
10.8.3 Product benchmarking
10.8.4 Strategic Initiatives
10.9 GlaxoSmithKline plc
10.9.1 Company overview
10.9.2 Financial performance
10.9.3 Product benchmarking

List of Tables
Table 1 Global pharmaceutical fine chemicals market estimates & forecasts, in cardiovascular, 2014 - 2025 (USD billion)
Table 2 Global pharmaceutical fine chemicals market estimates & forecasts, in cardiovascular, by region, 2014 - 2025 (USD Billion)
Table 3 Global pharmaceutical fine chemicals market estimates & forecasts, in neurology, 2014 - 2025 (USD billion)
Table 4 Global pharmaceutical fine chemicals market estimates & forecasts, in neurology, by region, 2014 - 2025 (USD Billion)
Table 5 Global pharmaceutical fine chemicals market estimates & forecasts, in oncology, 2014 - 2025 (USD billion)
Table 6 Global pharmaceutical fine chemicals market estimates & forecasts, in oncology, by region, 2014 - 2025 (USD Billion)
Table 7 Global pharmaceutical fine chemicals market estimates & forecasts, in infectious diseases, 2014 - 2025 (USD billion)
Table 8 Global pharmaceutical fine chemicals market estimates & forecasts, in infectious diseases, by region, 2014 - 2025 (USD Billion)
Table 9 Global pharmaceutical fine chemicals market estimates & forecasts, in metabolic system, 2014 - 2025 (USD billion)
Table 10 Global pharmaceutical fine chemicals market estimates & forecasts, in metabolic system, by region, 2014 - 2025 (USD Billion)
Table 11 Global pharmaceutical fine chemicals market estimates & forecasts, in diabetes, 2014 - 2025 (USD billion)
Table 12 Global pharmaceutical fine chemicals market estimates & forecasts, in diabetes, by region, 2014 - 2025 (USD Billion)
Table 13 Global pharmaceutical fine chemicals market estimates & forecasts, in respiratory diseases, 2014 - 2025 (USD billion)
Table 14 Global pharmaceutical fine chemicals market estimates & forecasts, in respiratory diseases, by region, 2014 - 2025 (USD Billion)
Table 15 Global pharmaceutical fine chemicals market estimates & forecasts, in gastrointestinal diseases, 2014 - 2025 (USD billion)
Table 16 Global pharmaceutical fine chemicals market estimates & forecasts, in gastrointestinal diseases, by region, 2014 - 2025 (USD Billion)
Table 17 Global pharmaceutical fine chemicals market estimates & forecasts, in musculoskeletal diseases, 2014 - 2025 (USD billion)
Table 18 Global pharmaceutical fine chemicals market estimates & forecasts, in musculoskeletal diseases, by region, 2014 - 2025 (USD Billion)
Table 19 Global pharmaceutical fine chemicals market estimates & forecasts, in other application, 2014 - 2025 (USD billion)
Table 20 Global pharmaceutical fine chemicals market estimates & forecasts, in other application, by region, 2014 - 2025 (USD Billion)
Table 21 Global proprietary pharmaceutical fine chemicals market estimates & forecasts, 2014 - 2025 (USD billion)
Table 22 Global proprietary pharmaceutical fine chemicals market estimates & forecasts, by region, 2014 - 2025 (USD Billion)
Table 23 Global non-proprietary pharmaceutical fine chemicals market estimates & forecasts, 2014 - 2025 (USD billion)
Table 24 Global non-proprietary pharmaceutical fine chemicals market estimates & forecasts, by region, 2014 - 2025 (USD Billion)
Table 25 Global pharmaceutical fine chemicals market estimates & forecasts, in small molecules, 2014 - 2025 (USD billion)
Table 26 Global pharmaceutical fine chemicals market estimates & forecasts, small molecules, by region, 2014 - 2025 (USD Billion)
Table 27 Global pharmaceutical fine chemicals market estimates & forecasts, in big molecules, 2014 - 2025 (USD billion)
Table 28 Global pharmaceutical fine chemicals market estimates & forecasts, in big molecules, by region, 2014 - 2025 (USD Billion)
Table 29 Global pharmaceutical fine chemicals market estimates & forecasts, in basic building blocks, 2014 - 2025 (USD billion)
Table 30 Global pharmaceutical fine chemicals market estimates & forecasts, in basic building blocks, by region, 2014 - 2025 (USD Billion)
Table 31 Global pharmaceutical fine chemicals market estimates & forecasts, in advanced intermediates, 2014 - 2025 (USD billion)
Table 32 Global pharmaceutical fine chemicals market estimates & forecasts, in advanced intermediates, by region, 2014 - 2025 (USD Billion)
Table 33 Global pharmaceutical fine chemicals market estimates & forecasts, in active ingredients, 2014 - 2025 (USD billion)
Table 34 Global pharmaceutical fine chemicals market estimates & forecasts, in active ingredients, by region, 2014 - 2025 (USD Billion)
Table 35 North America pharmaceutical fine chemicals market estimates & forecasts, 2014 - 2025 (USD billion)
Table 36 North America pharmaceutical fine chemicals market estimates & forecasts by application, 2014 - 2025 (USD billion)
Table 37 North America pharmaceutical fine chemicals market estimates & forecasts by type, 2014 - 2025 (USD billion)
Table 38 North America pharmaceutical fine chemicals market estimates & forecasts by size, 2014 - 2025 (USD billion)
Table 39 North America pharmaceutical fine chemicals market estimates & forecasts by product, 2014 - 2025 (USD billion)
Table 40 U.S. pharmaceutical fine chemicals market estimates & forecasts, 2014 - 2025 (USD billion)
Table 41 U.S. pharmaceutical fine chemicals market estimates & forecasts by application, 2014 - 2025 (USD billion)
Table 42 U.S. pharmaceutical fine chemicals market estimates & forecasts by type, 2014 - 2025 (USD billion)
Table 43 U.S. pharmaceutical fine chemicals market estimates & forecasts by size, 2014 - 2025 (USD billion)
Table 44 U.S. pharmaceutical fine chemicals market estimates & forecasts by product, 2014 - 2025 (USD billion)
Table 45 Europe pharmaceutical fine chemicals market estimates & forecasts, 2014 - 2025 (USD billion)
Table 46 Europe pharmaceutical fine chemicals market estimates & forecasts by application, 2014 - 2025 (USD billion)
Table 47 Europe pharmaceutical fine chemicals market estimates & forecasts by type, 2014 - 2025 (USD billion)
Table 48 Europe pharmaceutical fine chemicals market estimates & forecasts by size, 2014 - 2025 (USD billion)
Table 49 Europe pharmaceutical fine chemicals market estimates & forecasts by product, 2014 - 2025 (USD billion)
Table 50 Germany pharmaceutical fine chemicals market estimates & forecasts, 2014 - 2025 (USD billion)
Table 51 Germany. pharmaceutical fine chemicals market estimates & forecasts by application, 2014 - 2025 (USD billion)
Table 52 Germany. pharmaceutical fine chemicals market estimates & forecasts by type, 2014 - 2025 (USD billion)
Table 53 Germany pharmaceutical fine chemicals market estimates & forecasts by size, 2014 - 2025 (USD billion)
Table 54 Germany pharmaceutical fine chemicals market estimates & forecasts by product, 2014 - 2025 (USD billion)
Table 55 UK pharmaceutical fine chemicals market estimates & forecasts, 2014 - 2025 (USD billion)
Table 56 UK. pharmaceutical fine chemicals market estimates & forecasts by application, 2014 - 2025 (USD billion)
Table 57 UK. pharmaceutical fine chemicals market estimates & forecasts by type, 2014 - 2025 (USD billion)
Table 58 UK pharmaceutical fine chemicals market estimates & forecasts by size, 2014 - 2025 (USD billion)
Table 59 UK pharmaceutical fine chemicals market estimates & forecasts by product, 2014 - 2025 (USD billion)
Table 60 Asia Pacific pharmaceutical fine chemicals market estimates & forecasts, 2014 - 2025 (USD billion)
Table 61 Asia Pacific pharmaceutical fine chemicals market estimates & forecasts by application, 2014 - 2025 (USD billion)
Table 62 Asia Pacific pharmaceutical fine chemicals market estimates & forecasts by type, 2014 - 2025 (USD billion)
Table 63 Asia Pacific pharmaceutical fine chemicals market estimates & forecasts by size, 2014 - 2025 (USD billion)
Table 64 Asia Pacific pharmaceutical fine chemicals market estimates & forecasts by product, 2014 - 2025 (USD billion)
Table 65 China pharmaceutical fine chemicals market estimates & forecasts, 2014 - 2025 (USD billion)
Table 66 China pharmaceutical fine chemicals market estimates & forecasts by application, 2014 - 2025 (USD billion)
Table 67 China pharmaceutical fine chemicals market estimates & forecasts by type, 2014 - 2025 (USD billion)
Table 68 China pharmaceutical fine chemicals market estimates & forecasts by size, 2014 - 2025 (USD billion)
Table 69 China pharmaceutical fine chemicals market estimates & forecasts by product, 2014 - 2025 (USD billion)
Table 70 India pharmaceutical fine chemicals market estimates & forecasts, 2014 - 2025 (USD billion)
Table 71 India pharmaceutical fine chemicals market estimates & forecasts by application, 2014 - 2025 (USD billion)
Table 72 India pharmaceutical fine chemicals market estimates & forecasts by type, 2014 - 2025 (USD billion)
Table 73 India pharmaceutical fine chemicals market estimates & forecasts by size, 2014 - 2025 (USD billion)
Table 74 India pharmaceutical fine chemicals market estimates & forecasts by product, 2014 - 2025 (USD billion)
Table 75 Japan pharmaceutical fine chemicals market estimates & forecasts, 2014 - 2025 (USD billion)
Table 76 Japan pharmaceutical fine chemicals market estimates & forecasts by application, 2014 - 2025 (USD billion)
Table 77 Japan pharmaceutical fine chemicals market estimates & forecasts by type, 2014 - 2025 (USD billion)
Table 78 Japan pharmaceutical fine chemicals market estimates & forecasts by size, 2014 - 2025 (USD billion)
Table 79 Japan pharmaceutical fine chemicals market estimates & forecasts by product, 2014 - 2025 (USD billion)
Table 80 CSA pharmaceutical fine chemicals market estimates & forecasts, 2014 - 2025
Table 81 CSA pharmaceutical fine chemicals market estimates & forecasts, 2014 - 2025 (USD billion)
Table 82 CSA pharmaceutical fine chemicals market estimates & forecasts by application, 2014 - 2025 (USD billion)
Table 83 CSA pharmaceutical fine chemicals market estimates & forecasts by type, 2014 - 2025 (USD billion)
Table 84 CSA pharmaceutical fine chemicals market estimates & forecasts by size, 2014 - 2025 (USD billion)
Table 85 CSA pharmaceutical fine chemicals market estimates & forecasts by product, 2014 - 2025 (USD billion)
Table 86 MEA pharmaceutical fine chemicals market estimates & forecasts, 2014 - 2025 (USD billion)
Table 87 MEA pharmaceutical fine chemicals market estimates & forecasts by application, 2014 - 2025 (USD billion)
Table 88 MEA pharmaceutical fine chemicals market estimates & forecasts by type, 2014 - 2025 (USD billion)
Table 89 MEA pharmaceutical fine chemicals market estimates & forecasts by size, 2014 - 2025 (USD billion)
Table 90 MEA pharmaceutical fine chemicals market estimates & forecasts by product, 2014 - 2025 (USD billion)

List of Figures
FIG. 1 Pharmaceutical fine chemicals market share, 2016 (USD Billion)
FIG. 2 Pharmaceutical fine chemicals market segmentation
FIG. 3 Pharmaceutical fine chemicals market, 2014 - 2025 (USD Billion)
FIG. 4 Pharmaceutical fine chemicals value chain analysis
FIG. 5 Pharmaceutical fine chemicals market dynamics
FIG. 6 Incidence of heart attack or fatal coronary heart disease by age and sex in U.S.
FIG. 7 Key opportunities prioritized
FIG. 8 Pharmaceutical fine chemicals - Porter’s analysis
FIG. 9 Pharmaceutical fine chemicals - PESTLE analysis
FIG. 10 Global pharmaceutical fine chemicals market share by application, 2016 & 2025
FIG. 11 Global pharmaceutical fine chemicals market share by type, 2016 & 2025
FIG. 12 Global pharmaceutical fine chemicals market share by chemicals, 2016 & 2025
FIG. 13 Global pharmaceutical fine chemicals market share by product, 2016 & 2025
FIG. 14 Global pharmaceutical fine chemicals market share by region, 2016 & 2025
FIG. 15 Competitive strategy adopted by leading players
FIG. 16 Competitive strategy adopted by leading players

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Denisco Chemicals
  • Albemarle Corporation
  • Kenko Corporation
  • W. R. Grace & Co.
  • Chemada Fine Chemicals
  • Syntor Fine Chemicals
  • Johnson Matthey Fine Chemicals
  • Pfizer Inc
  • GlaxoSmithKline plc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll